DHA supplementation during pregnancy and lactation affects infants' cellular but not humoral immune response

Esther Granot*, Einat Jakobovich, Ruth Rabinowitz, Paloma Levy, Michael Schlesinger

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Background. It is currently recommended that diet of pregnant mothers contain 200-300 mgDHA/day. Aim. To determine whether DHA supplementation during pregnancy and lactation affects infants' immune response. Methods. 60 women in ≥3rd pregnancy studied; 30 randomly assigned to receive DHA 400 mg/day from 12th week gestation until 4 months postpartum. From breast-fed infants, blood obtained for anti-HBs antibodies, immunoglobulins, lymphocyte subset phenotyping, and intracellular cytokine production. Results. CD4+ lymphocytes did not differ between groups, but CD4CD45RA/CD4 (nave cells) significantly higher in infants in DHA+ group. Proportion of CD4 and CD8 cells producing IFN significantly lower in DHA+ group, with no differences in proportion of IL4-producing cells. Immunoglobulins and anti-HBs levels did not differ between groups. Conclusions. In infants of mothers receiving DHA supplementation, a higher percentage of CD4 nave cells and decreased CD4 and CD8 IFN production is compatible with attenuation of a proinflammatory response.

Original languageEnglish
Article number493925
JournalMediators of Inflammation
Volume2011
DOIs
StatePublished - 2011

Fingerprint

Dive into the research topics of 'DHA supplementation during pregnancy and lactation affects infants' cellular but not humoral immune response'. Together they form a unique fingerprint.

Cite this